English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

ConClusion: We present a validated risk stratification tool for predicting 30-day SSM following reduction mammoplasty using data that are readily available to the clinician. This may allow targeted screening and intervention in high-risk patients, better counseling, selective resident participation, and ultimately decrease overall health-care costs. This is the first study to date that provides a well-defined risk assessment tool to improve outcomes in reduction mammoplasty patients. Future studies should determine if implementation of our SSM risk score optimizes safety and reduces morbidity rates after reduction mammoplasty.

plastic and reconstructive surgery. global open

Abstract: Evaluation of a New Concept in Two-Stage Breast Reconstruction: Patient Controlled Tissue Expansion using the AeroForm CO2 Tissue Expander System